Matthew Wein sold $415 of MGX
See Remarks at Metagenomi, Inc.. 358 shares at an average of $1.16, traded Sep 8, 2026, filed Sep 10, 2026.
Score components
- +15RoleOfficer
- 0Trade size$415 at market
- 0Share of holdings soldSold 0.3% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-387816, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | SOpen-market sale Common Stock | -358 | $1.16 | $415 | 126,133 | 32 d ago |
Related signals
Other insiders at Metagenomi, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | MGXbuy Metagenomi, Inc. | Laurence Reid director | $23k 20,000 shares | - | |
| 30Weak | Metagenomi, Inc. | Jian Irish See Remarks | $2,479 2,140 shares | -1% | |
| 37Weak | Metagenomi, Inc. | Pamela Wapnick Chief Financial Officer | $2,214 1,911 shares | -1% | |
| 30Weak | Metagenomi, Inc. | Jian Irish See Remarks | $11k 6,390 shares | -2% | |
| 40Moderate | Metagenomi, Inc. | Brian C. Thomas Chief Executive Officer | $19k 10,785 shares | -0% | |
| 37Weak | Metagenomi, Inc. | Pamela Wapnick Chief Financial Officer | $2,758 1,576 shares | -2% | |
| 30Weak | Metagenomi, Inc. | Sarah B. Noonberg Chief Medical Officer | $9,168 5,239 shares | -5% | |
| 30Weak | Metagenomi, Inc. | Matthew Wein See Remarks | $348 199 shares | -1% | |
| 22Weak | MGXsell Metagenomi, Inc. | Pamela Wapnick Chief Financial Officer | $2,900 1,559 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.